FIREFLY NEUROSCIENCE, INC.
Close on Oct 19, 2026
- Market cap
- $20.58M
- P/E (TTM)
- –
- Dividend yield
- –
About Firefly Neuroscience
Services-Prepackaged Software, SIC 7372
Firefly Neuroscience, Inc. is an artificial intelligence medical technology company specializing in neurodiagnostics and clinical decision-support. Through its integrated Firefly Platform and FDA-cleared Evoke System, the company combines specialized hardware, cloud-based analytics, and an extensive electrophysiological database. Its technology captures and analyzes standardized electroencephalographic (EEG), event-related potential (ERP), and heart rate variability data to generate structured clinical reports. The platform serves healthcare providers, psychiatric practices, neurology offices, behavioral health clinics, and pharmaceutical partners conducting clinical trials.
The company operates across the United States, with its Evoke System deployed across more than 85 clinical sites as of December 31, 2025. It employs 17 full-time personnel and utilizes a third-party contract manufacturer based in the United States to produce its hardware systems. The provided text does not disclose the location of the company's corporate headquarters.
Summary of the business section of Firefly Neuroscience's latest annual report, written by StockData.
Company profile
Company
- Legal name
- FIREFLY NEUROSCIENCE, INC.
- Headquarters
- Kenmore, NY
- Address
- 1100 Military Road 14217
- Phone
- (888) 237-6412
- Employees
- 17, Dec 31, 2025
- Industry
- Services-Prepackaged Software
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- CBIZ Canada LLP, Toronto, ON, Canada
Stock & identifiers
- Ticker
- AIFF
- Exchange
- Nasdaq
- Shares outstanding
- 16M, Aug 4, 2026
- Public float
- $31.30M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-3 reverse, Aug 13, 2024; 1-for-10 reverse, Nov 13, 2023; 1-for-10 reverse, Oct 18, 2023; 3-for-1, Apr 22, 1997; 3-for-1, Jan 31, 1997
- SEC CIK
- 803578
- CUSIP
- 317970101
- ISIN
- US3179701012
- EIN
- 54-1167364
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Gregory Lipschitz | Interim CEO, Director | 933,891 |
| David DeCaprio | President and COO, Director | 77,866 |
| David Ian Johnson | Executive Chairman, Director | 557,885 |
| Jessica Lucia Paz | Chief Accounting Officer | – |
| Gil Issachar | Chief Technology Officer | 33,480 |
| Paul Krzywicki | Chief Financial Officer | – |
| Stella Vnook | Director | – |
| Brian M. Posner | Director | – |
| Arun Swarup Menawat | Director | 99,405 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Greg Lipschitz | $1.06M | $707.22K | $503.66K | $3 | – |
| FY2025 Jon Olsen | $44.91K | $6.46K | $503.66K | $3 | – |
| FY2024 Greg Lipschitz | $0 | $0 | $325.15K | $9 | – |
| FY2024 Jon Olsen | $742.97K | $399.80K | $325.15K | $9 | – |
| FY2023 Greg Lipschitz | $0 | $0 | $157.21K | $6 | – |
| FY2023 Jon Olsen | $168.38K | $9.93K | $157.21K | $6 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of the date of this report, we have 17 full-time employees.”
Corporate history
Events identified from SEC filings